Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 49.16M P/E - EPS this Y 9.80% Ern Qtrly Grth -
Income -69.2M Forward P/E -0.80 EPS next Y 33.90% 50D Avg Chg -13.00%
Sales 7.88M PEG - EPS past 5Y - 200D Avg Chg -11.00%
Dividend N/A Price/Book 0.31 EPS next 5Y - 52W High Chg -51.00%
Recommedations 1.70 Quick Ratio 5.06 Shares Outstanding 38.13M 52W Low Chg 10.00%
Insider Own 3.94% ROA -24.57% Shares Float 21.16M Beta 0.99
Inst Own 59.25% ROE -48.69% Shares Shorted/Prior 2.08M/1.96M Price 1.30
Gross Margin - Profit Margin - Avg. Volume 144,527 Target Price 4.54
Oper. Margin -946.19% Earnings Date May 9 Volume 28,668 Change -1.52%
About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Bolt Biotherapeutics, Inc. News
04/29/24 Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
03/21/24 Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
02/27/24 Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
12/21/23 Pacira Appoints Frank D. Lee as Chief Executive Officer
12/05/23 Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertuยฎ
11/20/23 Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?
11/09/23 Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
11/07/23 Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
10/24/23 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
10/23/23 Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress
10/18/23 Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancerโ€™s 2023 Annual Meeting
10/17/23 Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers
10/16/23 Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023
09/28/23 Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers
09/12/23 Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042
09/05/23 Bolt Biotherapeutics to Participate in September Investor Conferences
08/09/23 Bolt Biotherapeutics Second Quarter 2023 Earnings: Misses Expectations
08/07/23 Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
08/03/23 Bolt Biotherapeutics Initiates Phase 2 Clinical Studies of BDC-1001 in Patients With HER2-Positive Cancer
07/31/23 Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023
BOLT Chatroom

User Image DipBuyInvester Posted - 3 hours ago

$BOLT ๐Ÿ‘€๐Ÿ‘€๐Ÿ‘€๐Ÿ‘€๐Ÿ‘€๐Ÿ‘€๐Ÿ‘€๐Ÿ‘€๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ

User Image KradeTing1 Posted - 5 days ago

$BOLT

User Image ViractaTrader77 Posted - 6 days ago

$BOLT If u like bolt you like Sutro 1000x more

User Image DipBuyInvester Posted - 6 days ago

$BOLT ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ

User Image DipBuyInvester Posted - 6 days ago

$BOLT Strong buy rating. Only 35 m free float.Can explode anytime.

User Image WallStArb Posted - 6 days ago

$BOLT not that anyone should give a shit but I have been buying bs I our position 1.08 area last couple days - not looking to buy back same size as we are almost done with the Jan effect but 1.09 area was our buy back area

User Image DipBuyInvester Posted - 04/29/24

$BOLT

User Image rp6577 Posted - 04/28/24

$BOLT does anyone have an idea as to when we might see some data? I believe management have just said later this year?

User Image DipBuyInvester Posted - 04/27/24

$BOLT Have patience!! Going to be huge. HER2-Expressing Solid Tumors, gastric cancer, including gastroesophageal junction cancer

User Image ViractaTrader77 Posted - 04/27/24

Game Changer https://markets.businessinsider.com/news/stocks/sutro-biopharma-s-lead-ovarian-cancer-candidate-is-a-game-changer-analyst-sees-huge-upside-1032685474 $IBRX $IOVA $BOLT $IMNM

User Image KradeTing1 Posted - 04/26/24

$BOLT Snagged some 1.11s. News soon !!

User Image DipBuyInvester Posted - 04/25/24

$BOLT

User Image rp6577 Posted - 04/24/24

$BOLT getting interesting again ๐Ÿ”ฅ

User Image DipBuyInvester Posted - 04/24/24

$BOLT HER2-Expressing Solid Tumors, gastric cancer, including gastroesophageal junction cancer 84 Million in cash!! Huge upside potential!! Load the boat.

User Image DipBuyInvester Posted - 04/24/24

$BOLT Smelling aroma!! Easy 10x . Load the boat.

User Image stockymcstockface3 Posted - 04/24/24

$BOLT

User Image DipBuyInvester Posted - 04/22/24

$BOLT

User Image DipBuyInvester Posted - 04/22/24

$BOLT

User Image DipBuyInvester Posted - 04/19/24

$BOLT Huge upside is around the corner!!

User Image onemillion2012 Posted - 04/17/24

$VNDA stay strong. A cheap offer. The need to double the amount. So no dealer there. We are better of alone. Buylist $nktr $asmb $bolt All on speciel sale today.

User Image DipBuyInvester Posted - 04/17/24

$BOLT

User Image stockymcstockface3 Posted - 04/16/24

$BOLT

User Image DipBuyInvester Posted - 04/16/24

$BOLT

User Image DipBuyInvester Posted - 04/15/24

$BOLT

User Image ViractaTrader77 Posted - 04/14/24

ADC Buying Spreeโ€ฆ Sutro Biopharma up next? https://www.labiotech.eu/trends-news/antibody-drug-conjugates-investment-surge/ $STRO $CTMX $BOLT $XNCR

User Image ViractaTrader77 Posted - 04/13/24

$VINC $IMNM Key in ADC Space is to own a basket. https://twitter.com/BiotechTVHQ/status/1775900116924448891/mediaViewer?currentTweet=1775900116924448891&currentTweetUser=BiotechTVHQ $BOLT $CTMX

User Image WallStArb Posted - 04/13/24

@LabPsycho @telomerase @Digital_Waffle_Pirate @CharlesEscobar $BOLT ISAC tech needs some good drugs! Maybe $KRON can partner with them and piss both companies cash away together over the next 18 months

User Image Capitulation_0 Posted - 04/12/24

$BOLT worse ADT performer. Can they turn this shit around?

User Image DipBuyInvester Posted - 04/12/24

$BOLT

User Image DipBuyInvester Posted - 04/11/24

$BOLT When the PR comes out, it shows itโ€™s strength!! Always buy the dip!!

Analyst Ratings
HC Wainwright & Co. Buy Mar 22, 24
HC Wainwright & Co. Buy Aug 8, 23
HC Wainwright & Co. Buy Aug 3, 23
HC Wainwright & Co. Buy Jun 5, 23
HC Wainwright & Co. Buy May 26, 23
SVB Leerink Outperform May 12, 23
HC Wainwright & Co. Buy May 12, 23
HC Wainwright & Co. Buy Mar 30, 23
Morgan Stanley Equal-Weight Jan 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Quinn William P. Chief Financial Offi.. Chief Financial Officer Dec 12 Buy 0.97 11,829 11,474 36,272 12/13/23
ENGLEMAN EDGAR Director Director Nov 29 Sell 0.88 148,884 131,018 251,522 12/01/23
ENGLEMAN EDGAR Director Director Nov 21 Sell 0.9 1,943 1,749 269,587 11/22/23
Vivo Capital VIII, LLC 10% Owner 10% Owner Nov 21 Sell 0.9 3,400 3,060 111,662 11/22/23
ENGLEMAN EDGAR Director Director Nov 16 Sell 0.94 49,173 46,223 269,823 11/20/23
Vivo Capital VIII, LLC 10% Owner 10% Owner Nov 16 Sell 0.94 86,054 80,891 113,119 11/20/23
Novo Holdings A/S 10% Owner 10% Owner Jul 13 Sell 2.00 800,000 1,600,000 3,703,991 07/15/22
Perez Edith A. Chief Medical Office.. Chief Medical Officer Dec 22 Option 2.8 35,714 99,999 37,042 02/01/22
Perez Edith A. Chief Medical Office.. Chief Medical Officer Dec 22 Buy 10.65 1,328 14,143 1,328 02/01/22